Testosterone affects female CD4+ T cells in healthy individuals and autoimmune liver diseases
Authors:
- Lara HenzeLHLara Henze
- Nico WillNWNico Will
- Dakyung LeeDLDakyung Lee
- Victor HaasVHVictor Haas
- Christian CasarCCChristian Casar
- Jasper MeyerJMJasper Meyer
- Stephanie SteinSSStephanie Stein
- Franziska ManglerFMFranziska Mangler
- Silja SteinmannSSSilja Steinmann
- Tobias PochTPTobias Poch
- Jenny KrauseJKJenny Krause
- Johannes FussJFJohannes Fuss
Open Access
- 4 March 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (8)
Abstract
Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are autoimmune liver diseases with strong female predominance. They are caused by T cell–mediated injury of hepatic parenchymal cells, but the mechanisms underlying this sex bias are unknown. Here, we investigated whether testosterone contributes to T cell activation in women with PBC. Compared with sex- and age-matched healthy controls ( n = 23), cisgender (cis) women with PBC ( n = 24) demonstrated decreased testosterone serum levels and proinflammatory CD4 + T cell profile in peripheral blood. Testosterone suppressed the expression of TNF and IFN-γ by human CD4 + T cells in vitro. In trans men receiving gender-affirming hormone therapy (GAHT) ( n = 25), testosterone affected CD4 + T cell function by inhibiting Th1 and Th17 differentiation and by supporting the differentiation into regulatory Treg. Mechanistically, we provide evidence for a direct effect of testosterone on T cells using mice with T cell–specific deletion of the cytosolic androgen receptor. Supporting a role for testosterone in autoimmune liver disease, we observed an improved disease course and profound changes in T cell states in a trans man with AIH/primary sclerosing cholangitis (PSC) variant syndrome receiving GAHT. We here report a direct effect of testosterone on CD4 + T cells that may contribute to future personalized treatment strategies.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (FOR 5068,No. 429191104)
- Deutsche Forschungsgemeinschaft (No. 513826600)
- Deutsche Forschungsgemeinschaft; YAEL-Foundation; Helmut and Hannelore Greve Foundation (FOR 5068,No. 429191104)
- Deutsche Forschungsgemeinschaft; YAEL-Foundation; Helmut and Hannelore Greve Foundation (No. 513826600)
This publication has 66 references indexed in Scilit:
- Sex hormone signaling and regulation of immune functionImmunity, 2023
- Dynamic regulatory networks of T cell trajectory dissect transcriptional control of T cell state transitionMolecular Therapy Nucleic Acids, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- Sex-related factors in autoimmune liver diseasesSeminars in Immunopathology, 2018
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitisJournal of Hepatology, 2017
- EASL Clinical Practice Guidelines: Autoimmune hepatitisJournal of Hepatology, 2015
- Normal values of CD4 and CD8 lymphocyte subsets in healthy indian adults and the effects of sex, age, ethnicity, and smokingCytometry Part B: Clinical Cytometry, 2003
- Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United StatesClinical Immunology and Immunopathology, 1997
- Free and serum testosterone levels in 276 males: A comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controlsClinical Rheumatology, 1989
- Low plasma androgens in women with systemic lupus erythematosusArthritis & Rheumatism, 1987